Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
+5.95%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$16.6B
AUM Growth
+$951M
(+6.1%)
Cap. Flow
+$96.2M
Cap. Flow
% of AUM
0.58%
Top 10 Holdings %
Top 10 Hldgs %
7.86%
Holding
3,168
New
755
Increased
828
Reduced
689
Closed
831
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$104M |
| 2 |
Goldman Sachs
GS
|
+$103M |
| 3 |
Steel Dynamics
STLD
|
+$101M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$95.5M |
| 5 |
PepsiCo
PEP
|
+$95.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$145M |
| 2 |
Exxon Mobil
XOM
|
+$141M |
| 3 |
Microsoft
MSFT
|
+$140M |
| 4 |
Coca-Cola
KO
|
+$140M |
| 5 |
Broadcom
AVGO
|
+$129M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Industrials | 13.07% |
| 3 | Consumer Discretionary | 12.98% |
| 4 | Healthcare | 12.98% |
| 5 | Financials | 12.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Artisan Partners
APAM
$3.27B
| $683K | ﹤0.01% |
22,986
+11,800
| +105% | +$350K |
|
1302
Capital Southwest
CSWC
$1.26B
| $674K | ﹤0.01% |
+39,440
| New | +$674K |
|
1303
Embecta
EMBC
$876M
| $674K | ﹤0.01% |
+26,655
| New | +$674K |
|
1304
Kymera Therapeutics
KYMR
$3.3B
| $674K | ﹤0.01% |
27,002
-44,370
| -62% | -$1.11M |
|
1305
Ultrapar
UGP
$4.05B
| $673K | ﹤0.01% |
278,059
-2,741
| -1% | -$6.63K |
|
1306
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.29B
| $673K | ﹤0.01% |
+21,364
| New | +$673K |
|
1307
Alamo Group
ALG
$2.5B
| $668K | ﹤0.01% |
4,720
+1,913
| +68% | +$271K |
|
1308
Green Dot
GDOT
$754M
| $664K | ﹤0.01% |
41,994
-11,965
| -22% | -$189K |
|
1309
Leslie's
LESL
$62M
| $662K | ﹤0.01% |
+54,188
| New | +$662K |
|
1310
Hilltop Holdings
HTH
$2.19B
| $660K | ﹤0.01% |
21,983
-18,932
| -46% | -$568K |
|
1311
Direxion Daily S&P 500 Bull 3x Shares
SPXL
$5.81B
| $656K | ﹤0.01% |
10,558
+1,218
| +13% | +$75.7K |
|
1312
iShares Silver Trust
SLV
$20.4B
| $653K | ﹤0.01% |
29,649
-3,355
| -10% | -$73.9K |
|
1313
WisdomTree US High Dividend Fund
DHS
$1.31B
| $652K | ﹤0.01% |
+7,574
| New | +$652K |
|
|
HFRO
1314
Highland Opportunities and Income Fund
HFRO
$346M
| $650K | ﹤0.01% |
63,073
+907
| +1% | +$9.34K |
|
1315
Liberty All-Star Equity Fund
USA
$1.93B
| $642K | ﹤0.01% |
112,701
+48,546
| +76% | +$277K |
|
|
IGD
1316
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$466M
| $641K | ﹤0.01% |
118,542
+2,500
| +2% | +$13.5K |
|
1317
Rush Enterprises Class A
RUSHA
$4.42B
| $640K | ﹤0.01% |
18,353
-42,178
| -70% | -$1.47M |
|
1318
Stock Yards Bancorp
SYBT
$2.28B
| $637K | ﹤0.01% |
+9,806
| New | +$637K |
|
1319
Relay Therapeutics
RLAY
$700M
| $636K | ﹤0.01% |
+42,602
| New | +$636K |
|
|
HQH
1320
abrdn Healthcare Investors
HQH
$897M
| $634K | ﹤0.01% |
35,217
+2,700
| +8% | +$48.6K |
|
1321
CRISPR Therapeutics
CRSP
$5.08B
| $634K | ﹤0.01% |
+15,594
| New | +$634K |
|
1322
SPDR Portfolio S&P 500 Value ETF
SPYV
$28.4B
| $634K | ﹤0.01% |
16,298
-6,380
| -28% | -$248K |
|
1323
Shutterstock
SSTK
$715M
| $633K | ﹤0.01% |
12,008
-10,249
| -46% | -$540K |
|
1324
Sterling Infrastructure
STRL
$9.62B
| $632K | ﹤0.01% |
+19,273
| New | +$632K |
|
1325
Target Hospitality
TH
$876M
| $632K | ﹤0.01% |
+41,713
| New | +$632K |
|